Eyeing the Options for Treating Meibomian Gland Dysfunction and Dry Eye Disease

Access Activity

Overview / Abstract:

Dry eye disease (DED) is highly prevalent but frequently underdiagnosed and subsequently undertreated. Studies have demonstrated that meibomian gland dysfunction (MGD) is a leading cause of the development and progression of evaporative DED, caused by a deficient tear film lipid layer that leads to increased tear evaporation. New and emerging treatments with novel mechanisms of action are being investigated that manage the signs and symptoms of DED associated with MGD and offer the potential for improved quality of life and greater preservation of vision. In this continuing education monograph, experts in the field review the pathophysiology, burden, and risk factors associated with DED and MGD and assess the efficacy and safety of current and emerging therapies.


May 30, 2024


Optometry / Ophthalmology CE



Credits / Hours



This continuing education activity is provided by Vindico Medical Education.

Presenters / Authors / Faculty

Alice Epitropoulos,

Jennifer Loh

Sponsors / Supporters / Grant Providers

This activity is supported by an educational grant from Bausch + Lomb.

Keywords / Search Terms

Vindico Medical Education Meibomian Gland Dysfunction and Dry Eye Disease, Meibomian Gland Dysfunction, Dry Eye Disease Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map